Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2012-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2015-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2015530071-A |
titleOfInvention |
Cellulite evaluation method and cellulite effect drug evaluation method using fibrin 3 and / or sarcoglycan γ as an index |
abstract |
The present invention is a method for evaluating cellulite using the expression level of fibrin 3 and / or sarcoglycan γ in the collected skin sample as an index, and by using fibrin 3 and / or sarcoglycan γ as an index in cultured cells. The present invention relates to a method for evaluating an agent for improving, preventing, or treating cellulite. [Selection] Figure 1 |
priorityDate |
2012-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |